Literature DB >> 19317839

Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study.

C Bachert1, N Van Bruaene, E Toskala, N Zhang, H Olze, G Scadding, C M Van Drunen, J Mullol, L Cardell, P Gevaert, T Van Zele, S Claeys, C Halldén, K Kostamo, U Foerster, M Kowalski, K Bieniek, A Olszewska-Ziaber, E Nizankowska-Mogilnicka, A Szczeklik, M Swierczynska, M Arcimowicz, V Lund, W Fokkens, T Zuberbier, C Akdis, G Canonica, P Van Cauwenberge, P Burney, J Bousquet.   

Abstract

Chronic rhinosinusitis is one of the most common health care challenges, with significant direct medical costs and severe impact on lower airway disease and general health outcomes. The diagnosis of chronic rhinosinusitis (CRS) currently is based on clinical signs, nasal endoscopy and CT scanning, and therapeutic recommendations are focussing on 2 classes of drugs, corticosteroids and antibiotics. A better understanding of the pathogenesis and the factors amplifying mucosal inflammation therefore seems to be crucial for the development of new diagnostic and therapeutic tools. In an effort to extend knowledge in this area, the WP 2.7.2 of the GA(2)LEN network of excellence currently collects data and samples of 1000 CRS patients and 250 control subjects. The main objective of this project is to characterize patients with upper airway disease on the basis of clinical parameters, infectious agents, inflammatory mechanisms and remodeling processes. This collaborative research will result in better knowledge on patient phenotypes, pathomechanisms, and subtypes in chronic rhinosinusitis. This review summarizes the state of the art on chronic rhinosinusitis and nasal polyposis in different aspects of the disease. It defines potential gaps in the current research, and points to future research perspectives and targets.

Entities:  

Mesh:

Year:  2009        PMID: 19317839     DOI: 10.1111/j.1398-9995.2009.01964.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  28 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Sarah Peterson; Julie A Poposki; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

Review 3.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

Review 4.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

5.  Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans.

Authors:  Julie A Poposki; Aiko I Klingler; Whitney W Stevens; Anju T Peters; Kathryn E Hulse; Leslie C Grammer; Robert P Schleimer; Kevin C Welch; Stephanie S Smith; Douglas M Sidle; David B Conley; Bruce K Tan; Robert C Kern; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2016-10-12       Impact factor: 10.793

6.  Rhinosinusitis and asthma: a link for asthma severity.

Authors:  C Bachert; S E M Claeys; P Tomassen; T van Zele; N Zhang
Journal:  Curr Allergy Asthma Rep       Date:  2010-05       Impact factor: 4.806

7.  Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis.

Authors:  Pamela A Mudd; Rohit K Katial; Raeful Alam; Samantha Hohensee; Vijay Ramakrishnan; Todd T Kingdom
Journal:  Ann Allergy Asthma Immunol       Date:  2011-08-27       Impact factor: 6.347

8.  Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression.

Authors:  Kathryn E Hulse; James E Norton; Lydia Suh; Qiu Zhong; Mahboobeh Mahdavinia; Patrick Simon; Robert C Kern; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Roderick G Carter; Atsushi Kato; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-03-06       Impact factor: 10.793

9.  Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.

Authors:  Deepti R Nagarkar; Julie A Poposki; Bruce K Tan; Michael R Comeau; Anju T Peters; Kathryn E Hulse; Lydia A Suh; James Norton; Kathleen E Harris; Leslie C Grammer; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2013-05-17       Impact factor: 10.793

10.  Five-year risk of incident disease following a diagnosis of chronic rhinosinusitis.

Authors:  A G Hirsch; X S Yan; A S Sundaresan; B K Tan; R P Schleimer; R C Kern; T L Kennedy; J S Greene; B S Schwartz
Journal:  Allergy       Date:  2015-09-25       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.